Skip to main content
. 2017 Aug 8;17:528. doi: 10.1186/s12885-017-3524-x

Table 1.

Number of GOT1-bearing mice used in each analysis after treatment with sonidegib, 177Lu-octreotate, or a combination of both pharmaceuticals, and in control animals

Sonidegib 177Lu-octreotate Sonidegib +177Lu-octreotate Control
Tumor volume measurements 5 5a 5 6a
Dosimetric calculations - 5 5 -
Gene expression analysis 3 3 3 3a
Protein expression analysis 3 3 3 3

aData has been characterized in a previous publication [29]